Skip to main content

Dr. Reddy's to market generic version of popular statin


NEW YORK Dr. Reddy’s Labs will market a generic version of a popular cholesterol-lowering medication in the United States, according to published reports.

The Business Standard, an Indian newspaper, reported that Dr. Reddy’s planned to launch a version of Pfizer’s drug Lipitor (atorvastatin) in the next two to three years. Lipitor is the world’s top-selling drug, with sales of $7.8 billion in the United States and $13.65 billion worldwide in 2008, according to IMS Health.

Ranbaxy Labs will be the first to launch the drug in the United States, in 2011, once Pfizer’s patent expires.

This ad will auto-close in 10 seconds